• 1
    Liberati A., Altman D. G., Tetzlaff J., Mulrow C., Gøtzsche P. C., Ioannidis, J. P. A. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med 2009; 6: e1000100.
  • 2
    Spring B., Howe D., Berendsen M., McFadden H. G., Hitchcock K., Rademaker A. W., Hitsman B. Systematic review and meta-analysis of behavioral interventions to control smoking cessation-related weight gain. Addiction 2009; 104:147286.
  • 3
    Parsons A., Lycett D., Aveyard P. Response to Spring et al.: What is the best method to assess the effect of combined interventions for smoking cessation and post-cessation weight gain? Addiction 2011; 106: 6756.
  • 4
    Spring B., McFadden H. G., Rademaker A. W., Hitsman B. Behavioral interventions to promote smoking cessation and prevent weight gain: a reply. Addiction 2011; 106: 6745.
  • 5
    Friedman L. M., Furberg C. D., DeMets D. L. Fundamentals of Clinical Trials. 4th edn. New York, N.Y: Springer; 2010.
  • 6
    Piantadosi S. Clinical Trials: A Methodologic Perspective. 2nd edn. New York, N.Y: John Wiley; 2005.
  • 7
    Moher D., Jadad A. R., Nichol G., Penman M., Tugwell P., Walsh S. Assessing the Quality of Randomized Controlled Trials: An Annotated Bibliography of Scales and Checklists. Control Clin Trials 1995; 16: 16273.
  • 8
    Bhogal S. K., Teasell R. W., Foley N. C., Speechley M. R. The PEDro scale provides a more comprehensive measure of methodological quality than the Jadad scale in stroke rehabilitation literature. J Clin Epidemiol 2005; 58: 66873.
  • 9
    Moher D., Schulz K. F., Altman D. G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Lancet 2001; 357: 119194.
  • 10
    Boutron I., Moher D., Altman D. G., Kenneth F. Schulz, K. F., Ravaud, P. for the CONSORT Group. Extending the CONSORT Statement to randomized trials of nonpharmacologic treatment: Explanation and elaboration. Ann Intern Med 2008; 148: 295309.
  • 11
    Mohr D. C., Spring B., Freedland K. E., Beckner V., Arean P., Hollon S. D., Ockene J., Kaplan R. The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychother Psychosom 2009; 78: 275284.
  • 12
    Hedeker D., Mermelstein R. J., Demirtas H. Analysis of binary outcomes with missing data: missing = smoking, last observation carried forward, and a little multiple imputation. Addiction 2007; 102: 156473.
  • 13
    Nelson D. B., Partin M. R., Fu S., Joseph A. M., An L. C. Why assigning ongoing tobacco use is not necessarily a conservative approach to handling missing tobacco cessation outcomes Nicotine Tob Res 2009; 11: 7783.
  • 14
    Schneider K. L., Hedeker D., Bailey K. C., Cook J. W., Spring B. A comment on analyzing addictive behaviors over time. Nicotine Tob Res 2010; 12: 4458.
  • 15
    Spring B., Pagoto S., Knatterud G., Kozak A., Hedeker, D. Examination of the analytic quality of behavioral health randomized clinical trials. J Clin Psychol 2007; 63: 5371
  • 16
    Pagoto S., Kozak A.T., John P., Bodenlos J., Hedeker D., Spring B. Intention-to-Treat Analyses in Behavioral Medicine Randomized Clinical Trials: The Impact of CONSORT. Int J Behav Med 2009; 16: 31622.
  • 17
    Danielsson T., Rossner S., Westin A. Open randomised trial of intermittent very low energy diet together with nicotine gum for stopping smoking in women who gained weight in previous attempts to quit [including commentary by Jones K]. BMJ 1999; 319: 4904.
  • 18
    Lycett D, Munafo M, Johnstone E, Murphy M, Aveyard P. Associations between weight change over 8 years and baseline body mass index in a cohort of continuing and quitting smokers. Addiction 2011; 106: 18896.